Fine Chemicals A Promising Outlook

摘要

The outlook for contract manufacturers looks promising despite cost pressures and Increased competition, pharmaceutical ingredient manufacturers say. Active pharma ingredient (API) and pharma intermediate producers plan further expansion of their activities, including investments in new geographies. Regulatory bodies, meanwhile, are tightening their scrutiny of the sector.